Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Female Reproductive SystemDRG 738-uterine-and-adnexa-procedures-for-ovarian-or-adnexal-malignancy-without-cc-mcc
    Ask Trek AI about this page

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    DRG 738 encompasses uterine and adnexa procedures for ovarian or adnexal malignancy without Major Complication or Comorbidity or Complication or Comorbidity. This Diagnosis-Related Group defines a payment grouping that influences Medicare inpatient reimbursement by reflecting the expected resource use for oncologic surgical admissions lacking additional coded severity.

    Customize your policy alerts

    Sign up for drg 738 policy alerts

    Get alerted when payer policies referencing 738 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 738 Overview

    DRG 738 covers inpatient cases involving uterine and adnexa procedures performed for ovarian or adnexal malignancy without a Major Complication or Comorbidity and without a Complication or Comorbidity. This Diagnosis-Related Group groups clinically similar surgical admissions to standardize Medicare payment for care focused on tumor-directed procedures such as oophorectomy, salpingo-oophorectomy, and affected uterine surgery when no higher-severity diagnoses are present. It matters for Medicare payment because classification into this Diagnosis-Related Group affects the base payment rate, resource intensity assumptions, and hospital reimbursement for these oncologic surgical admissions. Accurate coding of diagnoses and procedures determines assignment to this Diagnosis-Related Group and thus the appropriate inpatient payment.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative surgical technique and extent-of-surgery trials: randomized or prospective cohort studies comparing conservative uterine/adnexal-sparing surgeries versus more radical procedures in patients with ovarian or adnexal malignancy confined to the pelvis or early-stage disease. These studies enroll patients undergoing inpatient operative management to evaluate intraoperative outcomes (blood loss, operative time), short-term complications, and length of stay, addressing whether less extensive surgery can achieve similar oncologic control with fewer immediate postoperative complications. Results inform surgeons and hospitals on resource utilization, expected complication rates, and appropriate case-mix for DRG 738, which affects reimbursement and post-op utilization patterns for payers.
    • Comparative effectiveness studies of perioperative care pathways and enhanced recovery protocols: pragmatic trials or observational studies assessing different perioperative management strategies (e.g., enhanced recovery after surgery [ERAS] elements, thromboprophylaxis regimens, antibiotic timing, and pain control approaches) in patients admitted for uterine and adnexa procedures for ovarian/adnexal malignancy without major complications or comorbidities. These studies focus on inpatient metrics—time to ambulation, opioid consumption, length of stay, readmission rates—and may stratify by age, surgical approach (laparoscopic vs. open), and cancer stage. Findings are highly relevant to providers and payers because they identify care bundles that reduce LOS and complications within this DRG, thereby optimizing reimbursement, bed utilization, and post-discharge costs.
    • Post-discharge outcomes and survivorship cohort studies: longitudinal observational research tracking functional recovery, quality of life, recurrence monitoring, and healthcare utilization after discharge in patients who underwent uterine and adnexa procedures for ovarian/adnexal malignancy without CC/MCC. These studies enroll the typical DRG 738 population—patients with operative management and without major in-hospital complications—to quantify outpatient visits, adjuvant therapy initiation timing, and readmission reasons over months to years. This evidence helps payers and health systems predict downstream costs, design follow-up care pathways, and evaluate the value of inpatient care decisions on longer-term outcomes and total cost of care.

    Related Codes

    734-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITH-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy with CC/MCC: Inpatient Reimbursement Overview

    735-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITHOUT-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy: Inpatient Reimbursement Overview

    736-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    737-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    739-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    740-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    741-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    742-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITH-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy with CC/MCC: Inpatient Reimbursement Overview

    743-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy without CC/MCC: Inpatient Reimbursement Overview

    744-D-C-CONIZATION-LAPAROSCOPY-AND-TUBAL-INTERRUPTION-WITH-CC-MCC

    D&C, Conization, Laparoscopy and Tubal Interruption with CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 24

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.